LMR Partners’s Roivant Sciences ROIV Stock Holding History

LMR Partners’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.23M	Buy	34,775 +18,025	+108%	+$533K	﹤0.01%	1010
2026 Q1	$464K	Hold	16,750	–	–	﹤0.01%	1091
2025 Q4	$363K	Sell	16,750 -240,000	-93%	-$4.74M	﹤0.01%	1176
2025 Q3	$3.88M	Sell	256,750 -187,694	-42%	-$2.32M	0.02%	577
2025 Q2	$5.01M	Hold	444,444	–	–	0.04%	447
2025 Q1	$4.48M	Sell	444,444 -200,001	-31%	-$2.16M	0.04%	444
2024 Q4	$7.62M	Sell	644,445 -200,000	-24%	-$2.36M	0.06%	297
2024 Q3	$9.74M	Sell	844,445 -360,723	-30%	-$4.11M	0.08%	219
2024 Q2	$12.7M	Buy	1,205,168 +754,162	+167%	+$8.26M	0.11%	170
2024 Q1	$4.75M	Buy	+451,006	New	+$4.86M	0.05%	343

Other funds holding ROIV

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

LMR Partners's ROIV Position: Q2 2026 in Review

LMR Partners increased its Roivant Sciences (ROIV) stake by 108% in Q2 2026, buying an estimated $533K and bringing the position to 34,775 shares worth $1.23M. The position accounts for ﹤0.01% of the portfolio, ranked #1010.

LMR Partners first reported a position in ROIV in Q1 2024 and has held it in 10 quarters since. The position peaked at $12.7M in Q2 2024. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

LMR Partners held 34,775 shares of Roivant Sciences worth $1.23M as of Q2 2026.
LMR Partners bought 18,025 Roivant Sciences shares in Q2 2026, an estimated $533K.
Roivant Sciences made up ﹤0.01% of LMR Partners's portfolio in Q2 2026, its #1010 holding.
LMR Partners first reported a position in Roivant Sciences in Q1 2024 and has held it in 10 quarters since.
LMR Partners's Roivant Sciences position peaked at $12.7M in Q2 2024.
498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on LMR Partners's 13F filing for Q2 2026, filed 14 Aug 2026.